Immco Diagnostics, Inc.

Immco Diagnostics, Inc. — FDA 510(k) Submissions

Immco Diagnostics, Inc. has submitted 55 FDA 510(k) premarket notifications since 1988, of which 55 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Extractable Antinuclear Antibody, Antigen And Control, Autoantibodies, Endomysial(tissue Transglutaminase), Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control, System, Test, Anticardiolipin Immunological, Antibodies, Gliadin . Use the specialty filter in the sidebar to narrow results.